# Chromium Acetyltaurate **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/chromium-acetyltaurate **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-04-04 **Evidence Score:** 2 / 10 **Category:** Mineral **Also Known As:** Chromium(III) acetyltaurate, Cr-acetyltaurate, Acetyltaurine chromium complex, Chromium acetyltaurinate ## Overview Chromium acetyltaurate is a synthetic chelated form of trivalent chromium (Cr3+) bound to acetyltaurine, theorized to enhance chromium bioavailability compared to simpler inorganic salts. No peer-reviewed clinical trials have been conducted to establish its efficacy, safety profile, or pharmacokinetic advantages in humans. ## Health Benefits • No documented health benefits (no clinical evidence available) • No studied therapeutic applications (no RCTs or trials found) • No biomedical uses established (research dossier contains no relevant data) • No safety profile determined (no human studies identified) • No mechanism of action described (no biochemical pathway data) ## Mechanism of Action Chromium acetyltaurate is theorized to deliver trivalent chromium (Cr3+) intracellularly, where Cr3+ may potentiate insulin receptor tyrosine kinase activity by facilitating oligomeric chromodulin (low-molecular-weight chromium-binding substance, LMWCr) binding. This interaction is proposed to amplify insulin signaling cascades involving IRS-1 phosphorylation and downstream GLUT4 translocation, though no in vitro or in vivo data specific to the acetyltaurate chelate have confirmed this mechanism. The acetyltaurine ligand is hypothesized to improve mucosal absorption and reduce gastrointestinal precipitation relative to chromium picolinate or chromium chloride, but this remains entirely speculative without published pharmacokinetic data. ## Clinical Summary As of the available research dossier, zero randomized controlled trials (RCTs), observational studies, or pharmacokinetic studies have been conducted on chromium acetyltaurate in human subjects. No animal model data have been published in peer-reviewed literature specifically isolating this chelate form for efficacy or safety outcomes. General chromium research in related forms (e.g., chromium picolinate, chromium nicotinate) has shown modest, inconsistent effects on fasting glucose and [insulin sensitivity](/ingredients/condition/weight-management), but these findings cannot be extrapolated to chromium acetyltaurate. The evidence base is therefore rated as absent, and no therapeutic claims can be substantiated. ## Nutritional Profile Chromium acetyltaurate is a chelated mineral compound combining trivalent chromium (Cr³⁺) with acetyl-taurine (N-acetyltaurine) as an organic ligand. It is classified as a mineral supplement form rather than a food, so it does not possess a broad macronutrient profile. Key constituents: • Elemental chromium (Cr³⁺): approximately 10–14% by molecular weight depending on the stoichiometry of the complex (estimated molecular weight ~300–350 g/mol for a 1:2 Cr-to-ligand ratio, yielding roughly 52 g Cr per mol or ~15% w/w chromium content). • N-acetyltaurine (2-acetamidoethanesulfonic acid): serves as the organic chelating moiety; each ligand molecule (~167 g/mol) contributes a sulfonic acid group and an acetylated amine, which may modestly support taurine-related biochemical pathways upon metabolic release. • No macronutrients (fat, carbohydrate, protein) in meaningful quantities. • No vitamins, fiber, or additional minerals present. • No significant caloric contribution. Bioavailability notes: The chelation of chromium with acetyltaurine is theorized to enhance gastrointestinal absorption compared to inorganic chromium salts (e.g., chromium chloride) by improving lipophilicity and passive transport across intestinal epithelia. However, no published pharmacokinetic or bioavailability studies specific to chromium acetyltaurate were identified. By analogy with other organic chromium chelates (e.g., chromium picolinate, chromium nicotinate), oral bioavailability of elemental chromium from such complexes is generally estimated at 1–5%, which is higher than the <1% absorption typical of inorganic trivalent chromium salts. The acetyltaurine ligand may undergo hydrolysis in the GI tract, potentially releasing free taurine, though the quantitative contribution to systemic taurine levels would be negligible at typical supplemental doses (providing 200–1000 µg elemental Cr per day). No data exist on tissue distribution, half-life, or renal excretion specific to this compound. ## Dosage & Preparation No clinically studied dosages exist for Chromium Acetyltaurate. No forms, preparations, or dosing protocols have been established in medical literature. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions No human safety data, toxicology studies, or adverse event reports exist specifically for chromium acetyltaurate, making its risk profile entirely undetermined. By analogy with other trivalent chromium supplements, potential concerns include nephrotoxicity and hepatotoxicity at high doses, as documented in isolated case reports involving chromium picolinate. Chromium compounds broadly may interact with insulin, metformin, and other antidiabetic medications by additively lowering [blood glucose](/ingredients/condition/weight-management), and may reduce absorption of [thyroid](/ingredients/condition/hormonal) medications (levothyroxine) and antacids containing calcium carbonate. Chromium acetyltaurate should be avoided during pregnancy and lactation due to the complete absence of reproductive safety data. ## Scientific Research No clinical trials, RCTs, meta-analyses, or PubMed PMIDs exist for Chromium Acetyltaurate. The research dossier explicitly states there is no clinical evidence or biomedical documentation for this compound. ## Historical & Cultural Context No historical or traditional medicinal use documented for Chromium Acetyltaurate in any cultural system. The compound lacks any recorded traditional applications. ## Synergistic Combinations No synergistic ingredients identified due to lack of research ## Frequently Asked Questions ### What is chromium acetyltaurate and how does it differ from chromium picolinate? Chromium acetyltaurate is a chelated form of trivalent chromium (Cr3+) bound to acetyltaurine, whereas chromium picolinate pairs Cr3+ with picolinic acid. The acetyltaurate chelate is theorized to offer superior mucosal absorption by leveraging the taurine derivative as a membrane-compatible carrier, but no published pharmacokinetic head-to-head studies exist to confirm any bioavailability advantage over chromium picolinate or other commercial forms. ### Are there any clinical trials on chromium acetyltaurate? No randomized controlled trials, pilot studies, or published observational data on chromium acetyltaurate in humans have been identified in the peer-reviewed literature. This distinguishes it from better-studied chromium forms such as chromium picolinate, which has been evaluated in dozens of RCTs examining glycemic control and insulin sensitivity. Until clinical trials are conducted, no evidence-based conclusions about its efficacy or safety can be drawn. ### Can chromium acetyltaurate help with blood sugar or insulin resistance? There is no clinical evidence that chromium acetyltaurate improves blood glucose, HbA1c, or insulin sensitivity in humans. The theoretical basis for such an effect rests on chromium's proposed role in activating chromodulin (LMWCr), which may amplify insulin receptor signaling, but this mechanism has not been studied for the acetyltaurate chelate specifically. Individuals seeking chromium supplementation for glycemic support should consult a clinician and consider forms with at least some clinical data, such as chromium picolinate. ### Is chromium acetyltaurate safe to take daily? The daily safety of chromium acetyltaurate is unknown because no human toxicology or dose-ranging studies have been published. The U.S. Adequate Intake (AI) for chromium in adults is 25–35 mcg/day, and the Tolerable Upper Intake Level (UL) has not been formally established by the Institute of Medicine due to insufficient data on any chromium form. Given the absence of safety data specific to this chelate, daily use carries undetermined risk, and supplementation without medical supervision is not advisable. ### Does chromium acetyltaurate interact with any medications? No drug interaction studies specific to chromium acetyltaurate have been conducted. However, by class extrapolation, trivalent chromium supplements may potentiate the glucose-lowering effects of insulin, metformin, and sulfonylureas, potentially increasing hypoglycemia risk. Chromium can also chelate with levothyroxine and reduce its absorption when taken concurrently, and calcium carbonate or proton pump inhibitors may alter chromium absorption by modifying gastric pH. ### What foods naturally contain chromium acetyltaurate? Chromium acetyltaurate is not found in food sources; it is a synthesized supplement form created by combining chromium with acetyl-L-taurine. While chromium occurs naturally in foods like broccoli, green beans, and whole grains, these contain inorganic chromium rather than this specific chelated form. Chromium acetyltaurate is only available as a manufactured dietary supplement. ### Is chromium acetyltaurate safe for pregnant women or children? There are no human safety studies on chromium acetyltaurate in pregnant women or children, so safety cannot be established for these populations. Medical guidance on this ingredient cannot be provided without clinical research data. Pregnant women and parents should consult a healthcare provider before considering supplementation with untested mineral forms. ### What does the current research say about chromium acetyltaurate's effectiveness? No clinical trials or peer-reviewed research studies have evaluated chromium acetyltaurate's effectiveness for any health condition. The lack of scientific evidence means its mechanisms of action and potential benefits remain completely unstudied. Any claims about its efficacy should be viewed with caution until rigorous clinical research is conducted. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*